{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:13:24Z","timestamp":1761804804456,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofcardiologycases.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology Cases"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.jccase.2014.02.003","type":"journal-article","created":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T10:21:39Z","timestamp":1395742899000},"page":"226-229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of tolvaptan in a patient with right-sided heart failure and renal dysfunction refractory to diuretic therapy"],"prefix":"10.1016","volume":"9","author":[{"given":"Yumiko","family":"Joko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Ikemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuo","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukinori","family":"Ikegami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Fuse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munehisa","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiko","family":"Momiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jccase.2014.02.003_bib0005","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.amjmed.2006.09.014","article-title":"Practical applications of intravenous diuretic therapy in decompensated heart failure","volume":"119","author":"Cleland","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.jccase.2014.02.003_bib0010","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ejheart.2007.07.011","article-title":"Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial","volume":"9","author":"Hasselblad","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jccase.2014.02.003_bib0015","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1253\/circj.CJ-11-0267","article-title":"Predictors of long-term adverse outcomes in elderly patients over 80 years hospitalized with heart failure: a report from Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD)","volume":"75","author":"Hamaguchi","year":"2011","journal-title":"Circ J"},{"key":"10.1016\/j.jccase.2014.02.003_bib0020","doi-asserted-by":"crossref","first-page":"F273","DOI":"10.1152\/ajprenal.00195.2005","article-title":"Vasopression-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure","volume":"290","author":"Costello-Boerrigter","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jccase.2014.02.003_bib0025","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","article-title":"Short-term clinical effects of tolvaptan, an oral vasopression antagonist, in patients hospitalized for heart failure: the EVEREST clinical status trials","volume":"297","author":"Gheorghiade","year":"2007","journal-title":"JAMA"},{"issue":"Suppl. 1","key":"10.1016\/j.jccase.2014.02.003_bib0030","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1007\/s10557-011-6304-x","article-title":"Efficacy and safety of tolvaptan in heart failure patients with volume overload despite the standard treatment with conventional diuretics: a phase III, randomized, double-blind, placebo-controlled study (QUEST study)","volume":"25","author":"Matsuzaki","year":"2011","journal-title":"Cardiovasc Drug Ther"},{"issue":"Suppl. 1","key":"10.1016\/j.jccase.2014.02.003_bib0035","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1007\/s10557-011-6350-4","article-title":"Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failure","volume":"25","author":"Onogawa","year":"2011","journal-title":"Cardiovasc Drug Ther"},{"key":"10.1016\/j.jccase.2014.02.003_bib0040","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2459\/JCM.0b013e328355a740","article-title":"Efficacy of oral tolvaptan in acute heart failure patients with hypotension and renal impairment","volume":"13","author":"Vaduganathan","year":"2012","journal-title":"J Cardiovasc Med"},{"key":"10.1016\/j.jccase.2014.02.003_bib0045","first-page":"51","article-title":"Clinical utility of tolvaptan in the management of hyponatremia in heart failure patients","volume":"3","author":"Nodari","year":"2010","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"10.1016\/j.jccase.2014.02.003_bib0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jjcc.2012.08.020","article-title":"Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure in high-risk population","volume":"61","author":"Matsue","year":"2013","journal-title":"J Cardiol"},{"key":"10.1016\/j.jccase.2014.02.003_bib0055","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCHEARTFAILURE.111.965392","article-title":"Chronic administration of oral vasopression type 2 receptor antagonist tolvaptan exerts both myocardial and renal protective effects in rats with hypertensive heart failure","volume":"5","author":"Morooka","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jccase.2014.02.003_bib0060","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","article-title":"Importance of venous congestion for worsening of renal function in advanced decompensated heart failure","volume":"53","author":"Mullens","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jccase.2014.02.003_bib0065","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"}],"container-title":["Journal of Cardiology Cases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878540914000292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878540914000292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:09:08Z","timestamp":1761804548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878540914000292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1878540914000292"],"URL":"https:\/\/doi.org\/10.1016\/j.jccase.2014.02.003","relation":{},"ISSN":["1878-5409"],"issn-type":[{"type":"print","value":"1878-5409"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of tolvaptan in a patient with right-sided heart failure and renal dysfunction refractory to diuretic therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology Cases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jccase.2014.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}